Excerpts from CGS-CIMB report

Analyst: ONG Khang Chuen, CFA

Signs of a recovery
■ We expect sequential earnings recovery in 2H20F as Sunsine benefits from stronger sales volume amid downstream demand recovery.

China Sunsine

Share price: 
34 c

Target: 
42 c

■ Rubber accelerator prices are at an 18-year low; we expect ASPs to improve in coming months, helped by stronger demand and rising raw material costs.

■ Reiterate Add with higher TP of S$0.42, as we think the worst is over.

Valuation is attractive as Sunsine is backed by net cash of S$0.27/share.


Downstream demand upturn to drive volume growth
We forecast Sunsine’s sales volume to improve to 87.9kt (+15% hoh, +3% yoy) in 2HFY20F, driven by downstream demand recovery.

Domestically, industrial production for the tyre manufacturing industry (Aug: +3% mom, +9% yoy) is riding on an upturn in the automobile industry, as China has launched various government stimulus and policies to promote domestic consumption.

Meanwhile, export volume of China’s rubber accelerators (Aug: +34% mom, -3% yoy) have also picked up in recent months, as overseas economies gradually emerge from lockdowns.

We estimate that Sunsine is currently able to achieve a healthy utilisation rate of c.90%, even with the 20kt capacity expansion in Jun.

ASP showing signs of recovery
tbss9.14bRubber accelerators at China Sunsine plant.
NextInsight file photo
Post a two-year downtrend, we are seeing signs of a recovery for Sunsine’s ASP.

Rubber accelerator and anti-oxidant prices rose 1% and 17%, respectively, in Sep (on a mom basis), and we see further recovery in coming months, driven by

1) continued downstream demand recovery and

2) rise in raw material costs.

Aniline, a key raw material, saw a price uptick in Sep (+8% mom) as producers’ inventory levels return to a more normalised level.

We expect Sunsine to achieve a sequential earnings recovery in 2H20F, and forecast net profit of Rmb109m (+32% hoh, -12% yoy).

Maintain Add with a higher TP of S$0.42

We raise our FY20-22F EPS forecasts by 5.1-7.3% to reflect higher volume growth assumptions.

OngKhangChuen"Valuation is attractive as Sunsine is currently trading at 6.7x CY21F P/E, and downside risk is cushioned by its net cash of S$0.27/share. Potential re-rating catalyst is a recovery of Sunsine’s margin spreads."

-- ONG Khang Chuen, CFA

Our TP is lifted to S$0.42 as we roll forward our valuation, now based on 0.72x FY21F P/BV (-0.75 s.d. of historical mean since public listing).

Maintain Add, as we think the worst is over for China Sunsine, and recommend investors to accumulate at this level.

Key risks include worse-than-expected pricing competition or resurgence of Covid-19 impacting demand.


Full report here.


Share Prices

Counter NameLastChange
AEM Holdings3.470-0.120
Avarga0.250-0.005
Avi-Tech Electronics0.435-
Best World Int.1.360-
CEI0.915-
China Sunsine0.4350.015
CNMC GoldMine0.3000.005
CSE Global0.460-
Food Empire0.5900.005
Golden Energy0.1550.004
GSS Energy0.0530.003
ISDN Holdings0.390-0.015
ISOTeam0.149-
IX Biopharma0.255-0.005
JB Foods0.560-
KSH Holdings0.330-
Medtecs Intl1.140-0.040
Moya Asia0.066-
Nordic Group0.215-
Oxley Holdings0.225-
Procurri0.290-
REX International0.136-
Riverstone3.700-0.010
Roxy-Pacific0.345-
SingMedical0.2600.005
Sri Trang Agro1.390-
Straco Corp.0.480-
Sunningdale Tech1.640-0.030
Sunpower Group0.5900.010
The Trendlines0.0890.001
UG Healthcare0.910-0.010
Uni-Asia Group0.405-0.005
Yangzijiang Shipbldg0.9750.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 881 guests and no members online